These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8605007)

  • 21. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
    Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
    Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of key active-site residues in flavocytochrome P450 BM3.
    Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 10-Undecynoic acid, an inhibitor of cytochrome P450 4A1, inhibits ethanolamine-specific phospholipid base exchange reaction in rat liver microsomes.
    Lenart J; Pikuła S
    Acta Biochim Pol; 1999; 46(1):203-10. PubMed ID: 10453996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3.
    Helvig C; Dishman E; Capdevila JH
    Biochemistry; 1998 Sep; 37(36):12546-58. PubMed ID: 9730827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of benzoate-para-hydroxylase, a cytochrome P450 (CYP53A1), from Aspergillus niger.
    Faber BW; van Gorcom RF; Duine JA
    Arch Biochem Biophys; 2001 Oct; 394(2):245-54. PubMed ID: 11594739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.
    Modi S; Paine MJ; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
    Biochemistry; 1996 Apr; 35(14):4540-50. PubMed ID: 8605204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An enzymatically active chimeric protein containing the hydrophilic form of NADPH-cytochrome P450 reductase fused to the membrane-binding domain of cytochrome b5.
    Gilep AA; Guryev OL; Usanov SA; Estabrook RW
    Biochem Biophys Res Commun; 2001 Jun; 284(4):937-41. PubMed ID: 11409883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty acid-induced alteration of the porphyrin macrocycle of cytochrome P450 BM3.
    Macdonald ID; Munro AW; Smith WE
    Biophys J; 1998 Jun; 74(6):3241-9. PubMed ID: 9635777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P450BM-3: absolute configuration of the primary metabolites of palmitic acid.
    Truan G; Komandla MR; Falck JR; Peterson JA
    Arch Biochem Biophys; 1999 Jun; 366(2):192-8. PubMed ID: 10356283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
    Fasan R; Chen MM; Crook NC; Arnold FH
    Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
    [No Abstract]   [Full Text] [Related]  

  • 31. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
    Murataliev MB; Klein M; Fulco A; Feyereisen R
    Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.
    Cupp-Vickery JR; Garcia C; Hofacre A; McGee-Estrada K
    J Mol Biol; 2001 Aug; 311(1):101-10. PubMed ID: 11469860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The substrate binding site of human liver cytochrome P450 2C9: an NMR study.
    Poli-Scaife S; Attias R; Dansette PM; Mansuy D
    Biochemistry; 1997 Oct; 36(42):12672-82. PubMed ID: 9335524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole.
    Dierks EA; Davis SC; Ortiz de Montellano PR
    Biochemistry; 1998 Feb; 37(7):1839-47. PubMed ID: 9485309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol consumption enhances fatty acid omega-oxidation, with a greater increase in male than in female rats.
    Ma X; Baraona E; Lieber CS
    Hepatology; 1993 Nov; 18(5):1247-53. PubMed ID: 8225232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique properties of purified, Escherichia coli-expressed constitutive cytochrome P4504A5.
    Hosny G; Roman LJ; Mostafa MH; Masters BS
    Arch Biochem Biophys; 1999 Jun; 366(2):199-206. PubMed ID: 10356284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrocatalytically driven omega-hydroxylation of fatty acids using cytochrome P450 4A1.
    Faulkner KM; Shet MS; Fisher CW; Estabrook RW
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7705-9. PubMed ID: 7644480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
    Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
    Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do substrates enter and products exit the buried active site of cytochrome P450cam? 2. Steered molecular dynamics and adiabatic mapping of substrate pathways.
    Lüdemann SK; Lounnas V; Wade RC
    J Mol Biol; 2000 Nov; 303(5):813-30. PubMed ID: 11061977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2M1: cloning, sequencing, and expression of a new cytochrome P450 from rainbow trout liver with fatty acid (omega-6)-hydroxylation activity.
    Yang YH; Wang JL; Miranda CL; Buhler DR
    Arch Biochem Biophys; 1998 Apr; 352(2):271-80. PubMed ID: 9587416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.